Charles W. Finn, Ph.D. - Managing Director and Chief Executive Officer

Dr. Finn is responsible for the overall direction of RRD and the management of RRD's core development teams. Dr. Finn has twenty years of experience in the research, development and government regulation of biological and pharmaceutical products covering a wide range of product types and therapeutic indications. Dr. Finn began his career as a Staff Fellow at FDA, Center for Biologics Evaluation and Research and then entered industry where he has held senior positions of increasing responsibility in regulatory affairs and product development with several companies including Lederle-Praxis Biologicals, Miles Pharmaceuticals, Genetics Institute, BRI International, Quintiles, and Prestwick Clinical. Dr. Finn has extensive experience in establishing and managing drug development project teams.